150 related articles for article (PubMed ID: 30478003)
1. Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany.
Matysiak-Klose D; Santibanez S; Schwerdtfeger C; Koch J; von Bernuth H; Hengel H; Littmann M; Terhardt M; Wicker S; Mankertz A; Heininger U
Vaccine; 2018 Dec; 36(52):7916-7922. PubMed ID: 30478003
[TBL] [Abstract][Full Text] [Related]
2. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
[TBL] [Abstract][Full Text] [Related]
3. Post-exposure passive immunisation for preventing measles.
Young MK; Nimmo GR; Cripps AW; Jones MA
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010056. PubMed ID: 24687262
[TBL] [Abstract][Full Text] [Related]
4. The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles.
Young MK
Hum Vaccin Immunother; 2019; 15(9):2060-2065. PubMed ID: 31116633
[TBL] [Abstract][Full Text] [Related]
5. The optimal dose of disease-specific antibodies for post-exposure prophylaxis of measles and rubella in Australia: new guidelines recommended.
Young MK; Ng SK; Nimmo GR; Cripps AW
Expert Opin Drug Metab Toxicol; 2018 Jul; 14(7):663-669. PubMed ID: 29865869
[TBL] [Abstract][Full Text] [Related]
6. Influences on immunization rates: Vaccination coverage of mumps, measles, rubella and varicella before and after the STIKO intervention 2011 - A retrospective study.
Sanftenberg L; Schrörs HJ; Schelling J
Vaccine; 2016 Jul; 34(34):3938-41. PubMed ID: 27318420
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness and Safety of an Intravenous Immune Globulin (IVIG) Preparation in Post-exposure Prophylaxis (PEP) Against Measles in Infants.
Kohlmaier B; Holzmann H; Stiasny K; Leitner M; Zurl C; Strenger V; Kundi M; Zenz W
Front Pediatr; 2021; 9():762793. PubMed ID: 34926346
[No Abstract] [Full Text] [Related]
8. Updated NACI recommendations for measles post-exposure prophylaxis.
Tunis MC; Salvadori MI; Dubey V; Baclic O;
Can Commun Dis Rep; 2018 Sep; 44(9):226-230. PubMed ID: 31015814
[TBL] [Abstract][Full Text] [Related]
9. [Is complete immunity against measles a realistic target for patients with rheumatic diseases and how can it possibly be achieved?].
Braun J; Kiltz U; Müller-Ladner U
Z Rheumatol; 2020 Nov; 79(9):922-928. PubMed ID: 32945951
[TBL] [Abstract][Full Text] [Related]
10. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
[TBL] [Abstract][Full Text] [Related]
11. Do Australian immunoglobulin products meet international measles antibody titer standards?
Young MK; Bertolini J; Kotharu P; Maher D; Cripps AW
Hum Vaccin Immunother; 2017 Mar; 13(3):607-612. PubMed ID: 27763809
[TBL] [Abstract][Full Text] [Related]
12. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiological analysis of immunity against vaccine-preventable diseases: rubella, measles, mumps and chickenpox].
Buxbaum S; Doerr HW; Allwinn R
Dtsch Med Wochenschr; 2001 Nov; 126(46):1289-93. PubMed ID: 11709730
[TBL] [Abstract][Full Text] [Related]
14. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
Gerike E; Tischer A
Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
[TBL] [Abstract][Full Text] [Related]
15. Measles virus neutralizing antibodies in immunoglobulin lots produced from plasma collected in Europe or the United States.
Farcet MR; Karbiener M; Rabel PO; Schirmer A; Ilk R; Kreil TR
Vaccine; 2019 May; 37(24):3151-3153. PubMed ID: 31060953
[TBL] [Abstract][Full Text] [Related]
16. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
[No Abstract] [Full Text] [Related]
17. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
[TBL] [Abstract][Full Text] [Related]
18. [The active offering of measles, rubella and mumps vaccine in new mothers: the experience of health facilities in one of the Local Health Unit of Rome, Lazio, Italy].
Santoro V; Pettinicchio V; Lancia A; Vazzoler C; De Luca F; Franco E
Ig Sanita Pubbl; 2016; 72(6):589-597. PubMed ID: 28214912
[TBL] [Abstract][Full Text] [Related]
19. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
[TBL] [Abstract][Full Text] [Related]
20. Update on human rabies in a dog- and fox-rabies-free country.
Stahl JP; Gautret P; Ribadeau-Dumas F; Strady C; Le Moal G; Souala F; Maslin J; Fremont B; Bourhy H
Med Mal Infect; 2014 Jul; 44(7):292-301. PubMed ID: 25011930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
